# Integrated Summary of Effectiveness - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/integrated-summary-of-effectiveness/dceeebd6-6607-4d3c-beb9-417012c9a968

> FDA guidance document: Integrated Summary of Effectiveness. Issue date: October 08, 2015. Get complete insights and analysis.

---

## Details

- Title: Integrated Summary of Effectiveness
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2015-10-08
- Last Changed: 2022-02-25
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2008-D-0449">FDA-2008-D-0449</a>

## Related Documents

- [Limited Population Pathway for Antibacterial and Antifungal Drugs Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/limited-population-pathway-for-antibacterial-and-antifungal-drugs-guidance-for-industry/f01d33af-ed26-4eb5-961a-03e00c90f2c7)
- [Q14 Analytical Procedure Development](https://www.globalkeysolutions.net/guidances/guidance-document/q14-analytical-procedure-development/7f445a67-e90c-4c67-a0c6-958d21e1d405)
- [M12 Drug Interaction Studies](https://www.globalkeysolutions.net/guidances/guidance-document/m12-drug-interaction-studies/2ca5aef5-80cc-464b-ba2c-bd69d35dfc2d)